This paper reviews current knowledge on sources, spread and removal mechanisms of
antibiotic resistance genes (ARGs) in microbial communities of wastewaters, treatment …

Antibiotic-resistant bacteria that are difficult or impossible to treat are becoming increasingly
common and are causing a global health crisis. Antibiotic resistance is encoded by several …

Since its discovery in England and France in 1986, vancomycin-resistant Enterococcus has
increasingly become a major nosocomial pathogen worldwide. Enterococci are prolific …

Multidrug-resistant (MDR) enterococci are important nosocomial pathogens and a growing
clinical challenge. These organisms have developed resistance to virtually all antimicrobials …

Early in its evolution, Enterococcus faecium acquired traits that allowed it to become a
successful nosocomial pathogen. E. faecium inherent tenacity to build resistance to …

The discovery, commercialization, and routine administration of antimicrobial compounds to
treat infections revolutionized modern medicine and changed the therapeutic paradigm …

Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE
infections are difficult to treat since common therapeutic options including ampicillin and …

Daptomycin is a lipopeptide antibiotic produced by the soil bacterium Streptomyces
roseosporus that is clinically used to treat severe infections with Gram-positive bacteria. In …

The genus Enterococcus consists of facultative gram-positive cocci that have been isolated
from a variety of animals, plants, and environmental sources. Although 58 species have …

Daptomycin (DAP) is a cyclic lipopeptide with in vitro activity against a variety of Gram‐
positive pathogens, including multidrug‐resistant organisms. Since its introduction into …